CDCA2 Activators would denote a group of chemical compounds that specifically increase the activity of cell division cycle associated 2 (CDCA2), also known as Repo-Man. CDCA2 is a regulatory protein that is involved in various cell cycle processes, including the transition from metaphase to anaphase and the reestablishment of the nuclear envelope during telophase in mitosis. Activators of CDCA2 would be molecules that enhance its function in cell cycle regulation, possibly by increasing its expression levels, stabilizing the protein, or enhancing its interaction with other cell cycle regulatory proteins such as Protein Phosphatase 1 (PP1). These activators could encompass a range of chemical entities from small organic molecules to larger macromolecular complexes that are capable of engaging with CDCA2 to modulate its cellular activity.
The discovery and study of CDCA2 activators would likely involve complex and multifaceted approaches. Initial identification could be done using high-throughput chemical screening techniques to find molecules that can modulate the activity of CDCA2. Such screens may measure the phosphorylation status of cell cycle proteins downstream of CDCA2, or assay for the subcellular localization changes that are indicative of CDCA2 activity. Following the identification of molecules that can modulate CDCA2, further in vitro assays would be necessary to characterize these interactions. These might include mass spectrometry to identify potential post-translational modifications of CDCA2 induced by the activators or co-immunoprecipitation to study changes in CDCA2's interactions with its binding partners. Additionally, in-depth studies might be undertaken to elucidate the precise molecular mechanisms by which these activators enhance CDCA2 activity. For instance, structural studies using cryo-electron microscopy or X-ray crystallography could reveal the binding sites of the activators on CDCA2 or induce changes in CDCA2 conformation, providing insights into the molecular basis of activation. Such detailed characterization is essential for understanding the function of CDCA2 activators at the cellular and molecular levels.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
As an antimetabolite that causes DNA damage, 5-Fluorouracil could potentially induce CDCA2 expression as part of the cellular DNA damage response. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
This topoisomerase inhibitor induces DNA damage and could hypothetically increase CDCA2 expression as cells respond to DNA damage. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide, another topoisomerase inhibitor, could potentially upregulate CDCA2 expression in response to DNA strand breaks. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin is known for causing DNA damage and subsequent cell cycle arrest, which may affect CDCA2 expression as part of the damage response. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
This chemotherapeutic agent forms DNA cross-links, potentially increasing CDCA2 expression during the cellular response to DNA lesions. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Paclitaxel stabilizes microtubules and arrests cells in mitosis, which could lead to changes in CDCA2 expression as cells attempt to exit mitosis. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
By inhibiting dihydrofolate reductase and affecting DNA synthesis, Methotrexate might influence CDCA2 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
As a ribonucleotide reductase inhibitor, Hydroxyurea can cause DNA damage and may alter CDCA2 expression in response to this stress. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Involved in cell differentiation and growth, Retinoic Acid might influence CDCA2 expression through modulation of cell cycle-related genes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This histone deacetylase inhibitor affects chromatin structure and gene expression, and could hypothetically upregulate CDCA2. |